Summary
Johnson & Johnson (JNJ) announced on September 12, 2008, the upcoming retirement of Christine A. Poon, Vice Chairman of the Board and Worldwide Chairman of the Pharmaceuticals Group. Ms. Poon's retirement is effective March 1, 2009. This departure marks the end of a significant tenure for Ms. Poon, who joined the company in 2000 and held key leadership roles, including her board position since 2005. Investors should note that while this is a significant leadership change within the Pharmaceuticals Group, it is a planned retirement. The company has provided ample notice, allowing for a smooth transition. The press release attached as an exhibit offers further details on this event.
Key Highlights
- 1Christine A. Poon, Vice Chairman of the Board and Worldwide Chairman, Pharmaceuticals Group, has announced her retirement.
- 2Ms. Poon's retirement is scheduled to take effect on March 1, 2009.
- 3Ms. Poon began her career with Johnson & Johnson in 2000.
- 4She was elected to the Company's Board of Directors and named Vice Chairman in 2005.
- 5This is a planned retirement, not an unexpected departure.
- 6A press release detailing the retirement is attached as Exhibit 99.1.
Frequently Asked Questions
Christine A. Poon, Vice Chairman of the Board of Directors and Worldwide Chairman of the Pharmaceuticals Group, is retiring.
Her retirement is effective March 1, 2009.
Ms. Poon served as Vice Chairman of the Board and Worldwide Chairman of the Pharmaceuticals Group. She joined the company in 2000 and has been on the Board since 2005.
No, this is announced as a planned retirement with an effective date several months in the future, indicating a transition period.